From: scimedweb on
Recent review articles about pancreatic cancer:

Molecular biology of pancreatic cancer--new aspects and targets.
Schneider G, Hamacher R, Eser S, Friess H, Schmid RM, Saur D.
Anticancer Res. 2008 May-Jun;28(3A):1541-50.

Diagnosis and management of cystic neoplasms of the pancreas: an
evidence-based approach.
Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH,
Evans DB, Fleming JB.
J Am Coll Surg. 2008 Jul;207(1):106-20.

Molecular characterization of pancreatic neoplasms.
Shi C, Daniels JA, Hruban RH.
Adv Anat Pathol. 2008 Jul;15(4):185-95.

Artificial neural networks in pancreatic disease.
Bartosch-Härlid A, Andersson B, Aho U, Nilsson J, Andersson R.
Br J Surg. 2008 Jul;95(7):817-26.

Pancreatic cancer stem cells.
Lee CJ, Dosch J, Simeone DM.
J Clin Oncol. 2008 Jun 10;26(17):2806-12.

Novel advances in pancreatic cancer treatment.
Vulfovich M, Rocha-Lima C.
Expert Rev Anticancer Ther. 2008 Jun;8(6):993-1002.

Lessons from Tarceva in pancreatic cancer: where are we now, and how
should future trials be designed in pancreatic cancer?
Laurent-Puig P, Taieb J.
Curr Opin Oncol. 2008 Jul;20(4):454-8.

Present treatment and future expectations in advanced pancreatic
cancer.
Stathopoulos GP, Androulakis N, Souglakos J, Stathopoulos J,
Georgoulias V.
Anticancer Res. 2008 Mar-Apr;28(2B):1303-8.

Poor usage of HUGO standard gene nomenclature in cancer marker
studies.
Lacroix M.
Int J Biol Markers. 2008 April - June;23(2):123-126.

Immunotherapy of pancreatic carcinoma.
Märten A.
Rev Recent Clin Trials. 2008 May;3(2):121-5.

Molecular targeting in pancreatic cancer.
Wadler S.
Rev Recent Clin Trials. 2007 Jan;2(1):69-75.

Erlotinib-induced skin rash. Pathogenesis, clinical significance and
management in pancreatic cancer patients.
Saif MW, Merikas I, Tsimboukis S, Syrigos K.
JOP. 2008 May 8;9(3):267-74.

Pharmacogenomics and pancreatic cancer treatment. Optimizing current
therapy and individualizing future therapy.
Kang SP, Saif MW.
JOP. 2008 May 8;9(3):251-66.

Investigation of abdominal pain to detect pancreatic cancer.
Guthrie JA, Sheridan MB.
BMJ. 2008 May 10;336(7652):1067-9.

Current diagnosis and management of unusual pancreatic tumors.
Mortenson MM, Katz MH, Tamm EP, Bhutani MS, Wang H, Evans DB, Fleming
JB.
Am J Surg. 2008 Jul;196(1):100-13.

Mixed ductal-endocrine carcinoma of the pancreas with synchronous
papillary carcinoma-in-situ of the common bile duct: a case report and
literature review--synchronous pancreatic and bile duct tumors.
Carter RR, Woodall CE 3rd, McNally ME, Talboy GE, Lankachandra KM, Van
Way CW 3rd.
Am Surg. 2008 Apr;74(4):338-40.

Solid serous adenoma of the pancreas: an uncommon but important
entity.
Machado MC, Machado MA.
Eur J Surg Oncol. 2008 Jul;34(7):730-3.

Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving
pancreaticoduodenectomy (pp Whipple) for surgical treatment of
periampullary and pancreatic carcinoma.
Diener MK, Heukaufer C, Schwarzer G, Seiler CM, Antes G, Buchler MW,
Knaebel HP.
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006053.


(contact at InTextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb(a)mail.com)